172 related articles for article (PubMed ID: 6138434)
1. beta 1-selective adrenoceptor antagonists. 1. Synthesis and beta-adrenergic blocking activity of a series of binary (aryloxy)propanolamines.
Kierstead RW; Faraone A; Mennona F; Mullin J; Guthrie RW; Crowley H; Simko B; Blaber LC
J Med Chem; 1983 Nov; 26(11):1561-9. PubMed ID: 6138434
[TBL] [Abstract][Full Text] [Related]
2. Cardioselective beta-adrenergic blocking agents. 1. 1-((3,4-Dimethoxyphenethyl)amino)-3-aryloxy-2-propanols.
Hoefle ML; Hastings SG; Meyer RF; Corey RM; Holmes A; Stratton CD
J Med Chem; 1975 Feb; 18(2):148-52. PubMed ID: 235644
[TBL] [Abstract][Full Text] [Related]
3. Ultra-short-acting beta-adrenergic receptor blocking agents. 2. (Aryloxy)propanolamines containing esters on the aryl function.
Erhardt PW; Woo CM; Anderson WG; Gorczynski RJ
J Med Chem; 1982 Dec; 25(12):1408-12. PubMed ID: 6130154
[TBL] [Abstract][Full Text] [Related]
4. Beta-adrenergic blocking agents. 20. (3-Hydroxyprop-1-enyl)-substituted 1-(aryloxy)-3-(alkylamino)propan-2-ols.
Tucker H
J Med Chem; 1980 Oct; 23(10):1122-6. PubMed ID: 6106716
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of a novel series of (aryloxy)propanolamines: new selective beta 2-blocking agents.
Carre MC; Youlassani A; Caubere P; Saint-Aubin-Floch A; Blanc M; Advenier C
J Med Chem; 1984 Jun; 27(6):792-9. PubMed ID: 6145801
[TBL] [Abstract][Full Text] [Related]
6. beta-Adrenergic blocking agents. alpha- and gamma-methyl(aryloxy)propanolamines.
Lemke TL; Cramer MB; Adamski SW; Pedone CA; Brooker G
J Med Chem; 1981 Oct; 24(10):1211-4. PubMed ID: 6120233
[TBL] [Abstract][Full Text] [Related]
7. Beta 1-selective adrenoceptor antagonists. 3. 4-Azolyl-linked phenoxypropanolamines.
Machin PJ; Hurst DN; Bradshaw RM; Blaber LC; Burden DT; Melarange RA
J Med Chem; 1984 Apr; 27(4):503-9. PubMed ID: 6142955
[TBL] [Abstract][Full Text] [Related]
8. beta 1-selective adrenoceptor antagonists. 2. 4-ether-linked phenoxypropanolamines.
Machin PJ; Hurst DN; Bradshaw RM; Blaber LC; Burden DT; Fryer AD; Melarange RA; Shivdasani C
J Med Chem; 1983 Nov; 26(11):1570-6. PubMed ID: 6138435
[TBL] [Abstract][Full Text] [Related]
9. Beta-adrenergic blocking agents: substituted phenylalkanolamines. Effect of side-chain length on beta-blocking potency in vitro.
Fuhrer W; Ostermayer F; Zimmermann M; Meier M; Müller H
J Med Chem; 1984 Jul; 27(7):831-6. PubMed ID: 6145802
[TBL] [Abstract][Full Text] [Related]
10. Ultra-short-acting beta-adrenergic receptor blocking agents. 1. (Aryloxy)propanolamines containing esters in the nitrogen substituent.
Erhardt PW; Woo CM; Gorczynski RJ; Anderson WG
J Med Chem; 1982 Dec; 25(12):1402-7. PubMed ID: 6130153
[TBL] [Abstract][Full Text] [Related]
11. beta-Adrenergic blocking agents. 18. 1-(Aryloxy)-3-(arylthioalkylamino)propan-2-ols and 1-substituted alkylthioamino-3-(aryloxy)propan-2-ols.
Tucker H; Coope JF
J Med Chem; 1978 Aug; 21(8):769-73. PubMed ID: 29123
[TBL] [Abstract][Full Text] [Related]
12. New chiral and isomeric cyclopropyl ketoxime propanolamine derivatives with potent beta-adrenergic blocking properties.
Bouzoubaa M; Leclerc G; Rakhit S; Andermann G
J Med Chem; 1985 Jul; 28(7):896-900. PubMed ID: 2861288
[TBL] [Abstract][Full Text] [Related]
13. o-Chlorobenzenesulfonamidic derivatives of (aryloxy)propanolamines as beta-blocking/diuretic agents.
Cecchetti V; Fravolini A; Schiaffella F; Tabarrini O; Bruni G; Segre G
J Med Chem; 1993 Jan; 36(1):157-61. PubMed ID: 8093626
[TBL] [Abstract][Full Text] [Related]
14. Beta-adrenoceptor blocking agents. 1. Cardioselective 1-aryloxy-3-(aryloxyalkylamino)propan-2-ols.
Augstein J; Cox DA; Ham AL; Leeming PR; Snarey M
J Med Chem; 1973 Nov; 16(11):1245-51. PubMed ID: 4147835
[No Abstract] [Full Text] [Related]
15. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
16. 2-(Isoxazolylethenyl)phenoxypropanolamines: a new class of beta-receptor antagonists with antihypertensive activity.
Franke A; Frickel FF; Gries J; Lenke D; Schlecker R; Thieme PD
J Med Chem; 1981 Dec; 24(12):1460-4. PubMed ID: 6118439
[TBL] [Abstract][Full Text] [Related]
17. Ultra-short-acting beta-adrenergic receptor blocking agents. 3. Ethylenediamine derivatives of (aryloxy)propanolamines having esters on the aryl function.
Erhardt PW; Woo CM; Matier WL; Gorczynski RJ; Anderson WG
J Med Chem; 1983 Aug; 26(8):1109-12. PubMed ID: 6135805
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and beta-adrenergic antagonist activity of novel (3-cyanodihydropyridyl)propanolamines.
Vo D; Wolowyk MW; Knaus EE
Drug Des Discov; 1991 Dec; 8(2):157-64. PubMed ID: 1686561
[TBL] [Abstract][Full Text] [Related]
19. beta-Adrenergic blocking agents. 17. 1-Phenoxy-3-phenoxyalkylamino-2-propanols and 1-alkoxyalkylamino-3-phenoxy-2-propanols.
Smith LH; Tucker H
J Med Chem; 1977 Dec; 20(12):1653-6. PubMed ID: 22750
[TBL] [Abstract][Full Text] [Related]
20. Beta-adrenoceptor studies. 1. In vitro beta-adrenergic blocking, antiarrhythmic, and local anesthetic activities of a new series of aromatic bis(2-hydroxy-3-isopropylaminopropyl) ethers.
Zaagsma J; Nauta WT
J Med Chem; 1974 May; 17(5):507-13. PubMed ID: 4151492
[No Abstract] [Full Text] [Related]
[Next] [New Search]
